These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 38395061)

  • 21. TAM receptors in cardiovascular disease.
    McShane L; Tabas I; Lemke G; Kurowska-Stolarska M; Maffia P
    Cardiovasc Res; 2019 Jul; 115(8):1286-1295. PubMed ID: 30980657
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Gas6/TAM System and Multiple Sclerosis.
    Bellan M; Pirisi M; Sainaghi PP
    Int J Mol Sci; 2016 Oct; 17(11):. PubMed ID: 27801848
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Galectin-3 Stimulates Tyro3 Receptor Tyrosine Kinase and Erk Signalling, Cell Survival and Migration in Human Cancer Cells.
    Al Kafri N; Hafizi S
    Biomolecules; 2020 Jul; 10(7):. PubMed ID: 32664510
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gas6/TAM System: A Key Modulator of the Interplay between Inflammation and Fibrosis.
    Bellan M; Cittone MG; Tonello S; Rigamonti C; Castello LM; Gavelli F; Pirisi M; Sainaghi PP
    Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31614787
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Post-translational modifications of the ligands: Requirement for TAM receptor activation.
    Geng K
    Int Rev Cell Mol Biol; 2020; 357():35-55. PubMed ID: 33234244
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential regulation of hepatic physiology and injury by the TAM receptors Axl and Mer.
    Zagórska A; Través PG; Jiménez-García L; Strickland JD; Oh J; Tapia FJ; Mayoral R; Burrola P; Copple BL; Lemke G
    Life Sci Alliance; 2020 Aug; 3(8):. PubMed ID: 32571802
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Up-regulation of soluble Axl and Mer receptor tyrosine kinases negatively correlates with Gas6 in established multiple sclerosis lesions.
    Weinger JG; Omari KM; Marsden K; Raine CS; Shafit-Zagardo B
    Am J Pathol; 2009 Jul; 175(1):283-93. PubMed ID: 19541935
    [TBL] [Abstract][Full Text] [Related]  

  • 28. From MASH to HCC: the role of Gas6/TAM receptors.
    Apostolo D; Ferreira LL; Vincenzi F; Vercellino N; Minisini R; Latini F; Ferrari B; Burlone ME; Pirisi M; Bellan M
    Front Immunol; 2024; 15():1332818. PubMed ID: 38298195
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TAM-ing T cells in the tumor microenvironment: implications for TAM receptor targeting.
    Peeters MJW; Rahbech A; Thor Straten P
    Cancer Immunol Immunother; 2020 Feb; 69(2):237-244. PubMed ID: 31664482
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular profiling of TAM tyrosine kinase receptors and ligands in endometrial carcinoma: An in silico-study.
    Dilara Fatma Akin ; Özkan D
    Taiwan J Obstet Gynecol; 2023 Mar; 62(2):311-324. PubMed ID: 36965901
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TAM receptors Tyro3 and Mer as novel targets in colorectal cancer.
    Schmitz R; Valls AF; Yerbes R; von Richter S; Kahlert C; Loges S; Weitz J; Schneider M; Ruiz de Almodovar C; Ulrich A; Schmidt T
    Oncotarget; 2016 Aug; 7(35):56355-56370. PubMed ID: 27486820
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Axl and MerTK receptor tyrosine kinases maintain human macrophage efferocytic capacity in the presence of viral triggers.
    Grabiec AM; Goenka A; Fife ME; Fujimori T; Hussell T
    Eur J Immunol; 2018 May; 48(5):855-860. PubMed ID: 29400409
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tyro3, Axl, and Mertk receptor signaling in inflammatory bowel disease and colitis-associated cancer.
    Rothlin CV; Leighton JA; Ghosh S
    Inflamm Bowel Dis; 2014 Aug; 20(8):1472-80. PubMed ID: 24846720
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Duodenal mucosa of untreated celiac disease patients has altered expression of the GAS6 and PROS1 and the negative regulator tyrosine kinase TAM receptors subfamily.
    Perez F; Iribarren ML; Olexen CM; Ruera CN; Errasti AE; Guzman L; Garbi L; Carrera Silva EA; Chirdo FG
    Clin Immunol; 2024 Jun; 263():110202. PubMed ID: 38575045
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gas6/TAM Axis Involvement in Modulating Inflammation and Fibrosis in COVID-19 Patients.
    Rizzi M; Tonello S; D'Onghia D; Sainaghi PP
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674471
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of Vitamin K-Dependent Factors Protein S and GAS6 and TAM Receptors in SARS-CoV-2 Infection and COVID-19-Associated Immunothrombosis.
    Tutusaus A; Marí M; Ortiz-Pérez JT; Nicolaes GAF; Morales A; García de Frutos P
    Cells; 2020 Sep; 9(10):. PubMed ID: 32998369
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TAM receptors: A phosphatidylserine receptor family and its implications in viral infections.
    Ghosh Roy S
    Int Rev Cell Mol Biol; 2020; 357():81-122. PubMed ID: 33234246
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TAM receptors, Gas6, and protein S: roles in inflammation and hemostasis.
    van der Meer JH; van der Poll T; van 't Veer C
    Blood; 2014 Apr; 123(16):2460-9. PubMed ID: 24596417
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gas6/Axl pathway is activated in chronic liver disease and its targeting reduces fibrosis via hepatic stellate cell inactivation.
    Bárcena C; Stefanovic M; Tutusaus A; Joannas L; Menéndez A; García-Ruiz C; Sancho-Bru P; Marí M; Caballeria J; Rothlin CV; Fernández-Checa JC; de Frutos PG; Morales A
    J Hepatol; 2015 Sep; 63(3):670-8. PubMed ID: 25908269
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Requirement of Gamma-Carboxyglutamic Acid Modification and Phosphatidylserine Binding for the Activation of Tyro3, Axl, and Mertk Receptors by Growth Arrest-Specific 6.
    Geng K; Kumar S; Kimani SG; Kholodovych V; Kasikara C; Mizuno K; Sandiford O; Rameshwar P; Kotenko SV; Birge RB
    Front Immunol; 2017; 8():1521. PubMed ID: 29176978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.